Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Infographics

How New Price Transparency Rules May Impact Payers and Providers

Immediate considerations for the industry.

Principal, Oliver Wyman
Global Head, Health Services, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting

Whoever's closest to the consumer will be the gatekeeper of the industry.

Principal, Oliver Wyman
Engagement Manager, Oliver Wyman
Senior Consultant, Oliver Wyman

How not to be fooled, and why the old way is old news.

Principal, Health & Life Sciences, Oliver Wyman

Oral health can be the key driver of patients' ER bills. Proper care for the body’s “gateway” is a compelling value proposition for consumers and the healthcare ecosystem.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Asian healthcare is undergoing major disruption, and a new healthcare environment is emerging.

Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

There's big buzz around consumer behavior driving outcomes. But clinical data doesn't yet align with behavioral data.

Principal, Health & Life Sciences, Oliver Wyman

Healthcare companies should look to rebuild trust by doubling down on employee communications and fostering engagements that are driven by employees themselves.

Global Chair, Health, Edelman

They Just Have to Persuade People to Like Them

Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.

Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Pharma companies and providers in search of better solutions must look to the patient experience for answers.

Partner, Digital & Analytics, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

2018 was a big year for industry news. Here's what might happen next in artificial intelligence, the 2020 presidential election, pharma, and more.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights in your inbox

Subscribe